Correlation Between Valneva SE and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Exagen Inc, you can compare the effects of market volatilities on Valneva SE and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Exagen.

Diversification Opportunities for Valneva SE and Exagen

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Valneva and Exagen is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Valneva SE i.e., Valneva SE and Exagen go up and down completely randomly.

Pair Corralation between Valneva SE and Exagen

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Exagen. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.44 times less risky than Exagen. The stock trades about -0.07 of its potential returns per unit of risk. The Exagen Inc is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  392.00  in Exagen Inc on September 22, 2024 and sell it today you would earn a total of  123.00  from holding Exagen Inc or generate 31.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Exagen Inc

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Exagen Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Exagen

The main advantage of trading using opposite Valneva SE and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Valneva SE ADR and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals